ABO-incompatible kidney transplantation using both A2 and non-A2 living donors

James M. Gloor, Donna J. Lager, S. Breanndan Moore, Alvaro A. Pineda, Mary E. Fidler, Timothy S. Larson, Joseph P. Grande, Thomas R. Schwab, Matthew D. Griffin, Mikel Prieto,

Transplantation · 2003 · 202 citations · 18 references

Abstract

ABO-incompatible living donor kidney transplants can achieve an acceptable 1-year graft survival rate using an immunosuppressive regimen consisting of Thymoglobulin induction, tacrolimus, mycophenolate mofetil, and prednisone combined with pretransplant plasmapheresis, intravenous immunoglobulin, and splenectomy.

References

18